A few people talking about a lack of catalysts, here's a couple. 1) Raise the capital needed for the phase 2/3 study. The SP will be un- anchored from that point. 2) Amylyx's Relyvrio fails to meet its' phase 3 endpoints. BP will rush to buy PAA.
ODD, Healey platform and first dosing are others but first remove the elephant - raise the money for the study.
A few people talking about a lack of catalysts, here's a...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.5¢ | 17.5¢ | $427.5K | 2.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 103443 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 130237 | 3 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
0.005 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 18.5¢ | 17.5¢ | 1774886 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| PAA (ASX) Chart |